BioCentury
ARTICLE | Company News

Bayer, Kythera in deal for ATX-101

August 31, 2010 12:37 AM UTC

Kythera Biopharmaceuticals Inc. (Calabasas, Calif.) granted Bayer AG (Xetra:BAY) exclusive rights to co-develop and commercialize ATX-101 outside the U.S. and Canada. This year, the partners plan to b...